Position in REGN
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$2,696,810
-$2,040,245 QoQ
Shares Held
4,325
-29.5% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
#467
of 1,297 holders
Holding Since
Sep 2020
23 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026BRIGHTON JONES LLC holds $23,861,614 across 48 Biotechnology names. REGN ranks #3 (11.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INCY |
Incyte Corp
|
36,050 | $4,086,628 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
8,048 | $3,997,683 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
This page
|
4,325 | $2,696,810 | |
| 4 | EXEL |
Exelixis, Inc.
|
40,712 | $2,215,139 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
4,898 | $1,474,444 | |
| 6 | BMRN |
Biomarin Pharmaceutical Inc
|
17,246 | $986,816 | |
| 7 | RVMD |
Revolution Medicines, Inc.
|
3,466 | $649,112 | |
| 8 | CORT |
Corcept Therapeutics Inc
|
7,463 | $648,907 |
All Filings in REGN
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,696,810 | 4,325 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $4,737,055 | 6,131 | Shares | Sole | 2026-08-07 | |
| 2025-09-30 | $1,633,956 | 2,906 | Shares | Sole | 2025-10-14 | |
| 2025-06-30 | $299,775 | 571 | Shares | Sole | 2025-07-31 | |
| 2025-03-31 | $636,132 | 1,003 | Shares | Sole | 2025-04-17 | |
| 2024-12-31 | $675,288 | 948 | Shares | Sole | 2025-03-04 | |
| 2024-09-30 | $275,424 | 262 | Shares | Sole | 2025-03-04 | |
| 2024-06-30 | $966,947 | 920 | Shares | Sole | 2025-03-04 | |
| 2024-03-31 | $872,015 | 906 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $824,714 | 939 | Shares | Sole | 2024-02-05 | |
| 2023-09-30 | $774,405 | 941 | Shares | Sole | 2023-10-26 | |
| 2023-06-30 | $637,344 | 887 | Shares | Sole | 2023-07-31 | |
| 2023-03-31 | $751,828 | 915 | Shares | Sole | 2023-05-08 | |
| 2022-12-31 | $667,378 | 925 | Shares | Sole | 2023-02-03 | |
| 2022-09-30 | $643,404 | 934 | Shares | Sole | 2022-11-09 | |
| 2022-06-30 | $557,435 | 943 | Shares | Sole | 2022-08-04 | |
| 2022-03-31 | $699,816 | 1,002 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $511,531 | 810 | Shares | Sole | 2022-02-03 | |
| 2021-09-30 | $368,554 | 609 | Shares | Sole | 2021-11-04 | |
| 2021-06-30 | $310,548 | 556 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 | $228,053 | 482 | Shares | Sole | 2021-05-07 | |
| 2020-12-31 | $296,629 | 614 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $230,069 | 411 | Shares | Sole | 2020-11-12 | |
| No filing history on record for this holder in this stock. | ||||||